Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 3013-3019

  Arisawa, Tomiyasu ^a   Tahara, Tomomitsu ^b   Shiroeda, Hisakazu ^a   Yamada, Kaho ^a   Nomura, Tomoe ^a   Yamada, Hideto ^a   Hayashi, Ranji ^a   Matsunaga, Kazuhiro ^a   Otsuka, Toshimi ^a   Nakamura, Masakatsu ^a   Shimasaki, Takeo ^a   Toshikuni, Nobuyuki ^a   Kawada, Natsuko ^a   Shibata, Tomoyuki ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Gastric carcinogenesis; NFKB1 genetic polymorphism

Indexed keywords

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; DNA DENATURATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NFKB1 GENE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER;

AGED; CARCINOGENESIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 84892414754     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2768     Document Type: Article

References (43)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 827-841, 1999.
2. Parsonnet J, Friedman GD, Vandersteen DP, et al: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131, 1991.
3. No authors listed: NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272: 65-69, 1994.
4. Uemura N, Okamoto S, Yamamoto S, et al: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
5. El-Omar EM, Carrington M, Chow WH, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404: 398-402, 2000.
6. Wu MS, Wu CY, Chen CJ, Lin MT, Shun CT and Lin JT: Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 104: 617-623, 2003.
7. Ohyauchi M, Imatani A, Yonechi M, et al: The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 54: 330-335, 2005.
8. Arisawa T, Tahara T, Shibata T, et al: Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis. Oncol Rep 19: 223-228, 2008.
9. Arisawa T, Tahara T, Shiroeda H, et al: Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3′-UTR, influence susceptibility to gastric cancer. Hum Immunol 73: 747-752, 2012.
10. Kiechl S, Lorenz E, Reindl M, et al: Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347: 185-192, 2002.
11. Hoshino K, Takeuchi O, Kawai T, et al: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752, 1999.
12. Keates S, Hitti YS, Upton M and Kelly CP: Helicobacter pylori infection activates NF-kappaB in gastric epithelial cells. Gastroenterology 113: 1099-1109, 1997.
13. Hatz RA, Rieder G, Stolte M, et al: Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 112: 1908-1919, 1997.
14. Maeda S, Yoshida H, Ogura K, et al: H pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 119: 97-108, 2000.
15. Smith MG, Hold GL, Tahara E and El-Omar EM: Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12: 2979-2990, 2006.
16. Le Beau MM, Ito C, Cogswell P, Espinosa R III, Fernald AA and Baldwin AS Jr: Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappaB (NFKB2) and the I kappaB/MAD-3 (NFKBI) inhibitor of NF-kappaB to 4q24 and 14q13, respectively. Genomics 14: 529-531, 1992.
17. Zou YF, Yuan FL, Feng XL, et al: Association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer risk: a meta-analysis. Cancer Invest 29: 78-85, 2011.
18. Arisawa T, Tahara T, Shiroeda H, et al: NFKB1 polymorphism is associated with age-related gene methylation in Helicobacter pylori-infected subjects. Int J Mol Med 30: 255-262, 2012.
19. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.
20. Hayashi R, Tahara T, Yamaaki T, et al: -449 C>G polymorphism of NFKB1 gene, coding nuclear factor-kappaB, is associated with the susceptibility to ulcerative colitis. World J Gastroenterol 47: 6981-6986, 2012.
21. Lauren P: The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
22. Yoshimura T, Shimoyama T, Fukuda S, Tanaka M, Axon AT and Munakata A: Most gastric cancer occurs on the distal side of the endoscopic atrophic border. Scand J Gastroenterol 34: 1077-23.
23. Go MF: Review article: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16 (Suppl 1): S3-S15, 2002.
24. Kong X, Wang JL, Chen HM and Fang JY: Comparison of the clinicopathological characteristics of young and elderly patients with gastric carcinoma: a meta analysis. J Surg Oncol 106: 346-352, 2012.
25. Karban AS, Okazaki T, Panhuysen CI, et al: Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13: 35-45, 2004.
26. Li H, Gao L, Shen Z, et al: Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris. Arch Dermatol Res 300: 425-433, 2008.
27. Lo SS, Chen JH, Wu CW and Lui WY: Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients. Surgery 145: 280-285, 2009.
28. Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, et al: Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease. Genes Immun 8: 532-538, 2007.
29. Andersen V, Christensen J, Overvad K, Tjønneland A and Vogel U: Polymorphisms in NFκB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 10: 484, 2010.
30. Mirza MM, Fisher SA, Onnie C, et al: No association of the NFKB1 promoter polymorphism with ulcerative colitis in a British case control cohort. Gut 54: 1205-1206, 2005.
31. Glas J, Török HP, Tonenchi L, et al: Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes. Inflamm Bowel Dis 12: 606-611, 2006.
32. Bajwa EK, Cremer PC, Gong MN, et al: An NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among Caucasians. PLoS One 6: e19469, 2011.
33. Pereira SG and Oakley F: Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 40: 1425-1430, 2008.
34. de Winther MP, Kanters E, Kraal G and Hofker MH: Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 25: 904-914, 2005.
35. Lin L, DeMartino GN and Greene WC: Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92: 819-828, 1998.
36. Perkins ND: Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 8: 49-62, 2007.
37. Hayden MS and Ghosh S: Shared principles in NF-kappaB signaling. Cell 132: 344-362, 2008.
38. Gadjeva M, Tomczak MF, Zhang M, et al: A role for NF-kappaB subunits p50 and p65 in the inhibition of lipopolysaccharide-induced shock. J Immunol 173: 5786-5793, 2004.
39. Han W, Joo M, Everhart MB, et al: Myeloid cells control termination of lung inflammation through the NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 296: L320-L327, 2009.
40. Sasaki N, Morisaki T, Hashizume K, et al: Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 7: 4136-4142, 2001.
41. Kang MH, Oh SC, Lee HJ, et al: Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Exp Cell Res 317: 1746-1762, 2011.
42. Qin Y, Li L, Chen J, et al: Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-κB downregulation and PTEN upregulation in vitro. Oncol Res 20: 61-69, 2012.
43. Kim JG, Sohn SK, Chae YS, et al: No association of the NFKB1 insertion/deletion promoter polymorphism with survival in patients with gastric cancer. Jpn J Clin Oncol 39: 497-501, 2009.